{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:55:41Z","timestamp":1789052141667,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.clnesp.2023.02.020","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T02:49:44Z","timestamp":1677725384000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The association of circulating endocannabinoids with cancer cachexia: A cross-sectional study"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-7247","authenticated-orcid":false,"given":"Kazuki","family":"Ota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeko","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ichiro","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketoshi","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2023.02.020_bib1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1476-5381.2011.01327.x","article-title":"The endocannabinoid system and cancer: therapeutic implication","volume":"163","author":"Guindon","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clnesp.2023.02.020_bib2","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/febs.12152","article-title":"Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways","volume":"280","author":"Ueda","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.clnesp.2023.02.020_bib3","doi-asserted-by":"crossref","first-page":"R309","DOI":"10.1530\/EJE-16-1044","article-title":"Mechanisms in endocrinology: endocannabinoids and metabolism: past, present and future","volume":"176","author":"Simon","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clnesp.2023.02.020_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.orcp.2020.05.007","article-title":"The association of circulating endocannabinoids with appetite regulatory substances in obese women","volume":"14","author":"Lotfi Yagin","year":"2020","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.clnesp.2023.02.020_bib5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1189\/jlb.3RU0115-021R","article-title":"Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites","volume":"97","author":"Turcotte","year":"2015","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.clnesp.2023.02.020_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.critrevonc.2018.05.006","article-title":"Cancer cachexia: diagnosis, assessment, and treatment","volume":"127","author":"Sadeghi","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clnesp.2023.02.020_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2023.02.020_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00535-013-0787-0","article-title":"Cancer cachexia--pathophysiology and management","volume":"48","author":"Suzuki","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.02.020_bib9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnesp.2023.02.020_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clnesp.2023.02.020_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.clinbiochem.2017.07.011","article-title":"Biomarkers of cancer cachexia","volume":"50","author":"Loumaye","year":"2017","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clnesp.2023.02.020_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/apm.2018.08.04","article-title":"Health-related quality of life across cancer cachexia stages","volume":"8","author":"Kasvis","year":"2019","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.clnesp.2023.02.020_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/can.2021.0048","article-title":"The effect of cannabis-based medicine in the treatment of cachexia: a systematic review and meta-analysis","volume":"6","author":"Hammond","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.clnesp.2023.02.020_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/jpet.117.245704","article-title":"Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy","volume":"366","author":"Curry","year":"2018","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.clnesp.2023.02.020_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/jpet.119.262337","article-title":"The endocannabinoid system alleviates pain in a murine model of cancer-induced bone pain","volume":"373","author":"Thompson","year":"2020","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.clnesp.2023.02.020_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.brainresrev.2004.12.024","article-title":"New insights into COX-2 biology and inhibition","volume":"48","author":"Patrignani","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.clnesp.2023.02.020_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1527-3458.2006.00250.x","article-title":"Paracetamol: new vistas of an old drug","volume":"12","author":"Bertolini","year":"2006","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.clnesp.2023.02.020_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0083-6729(09)81011-X","article-title":"Glucocorticoid-regulated crosstalk between arachidonic acid and endocannabinoid biochemical pathways coordinates cognitive-, neuroimmune-, and energy homeostasis-related adaptations to stress","volume":"81","author":"Malcher-Lopes","year":"2009","journal-title":"Vitam Horm"},{"key":"10.1016\/j.clnesp.2023.02.020_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuroscience.2011.12.030","article-title":"Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis","volume":"204","author":"Hill","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.clnesp.2023.02.020_bib20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jnutbio.2014.03.012","article-title":"Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity","volume":"25","author":"Kim","year":"2014","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.clnesp.2023.02.020_bib21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1476-5381.2010.00790.x","article-title":"Endocannabinoid signalling: has it got rhythm?","volume":"160","author":"Vaughn","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clnesp.2023.02.020_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104471","article-title":"Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide)","volume":"111","author":"Hanlon","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.clnesp.2023.02.020_bib23","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.clnesp.2023.02.020_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jpainsymman.2009.03.012","article-title":"Validation of a simplified anorexia questionnaire","volume":"38","author":"Davis","year":"2009","journal-title":"J\u00a0Pain Symptom Manag"},{"key":"10.1016\/j.clnesp.2023.02.020_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1017\/S1478951504040507","article-title":"Reliability and validity of the Japanese version of the Support Team assessment Schedule (STAS-J)","volume":"2","author":"Miyashita","year":"2004","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.clnesp.2023.02.020_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative Oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clnesp.2023.02.020_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jchromb.2014.11.001","article-title":"A\u00a0quantitiative LC-MS\/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma","volume":"976\u2013977","author":"Gachet","year":"2015","journal-title":"J\u00a0Chromatogr, B: Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.clnesp.2023.02.020_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-3084(02)00068-3","article-title":"Chemical stability of 2-arachidonylglycerol under biological conditions","volume":"119","author":"Rouzer","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.clnesp.2023.02.020_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.18632\/oncoscience.33","article-title":"Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans","volume":"1","author":"Sailler","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.clnesp.2023.02.020_bib30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1182\/bloodadvances.2018030387","article-title":"Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO\/ASH clinical practice guideline update","volume":"3","author":"Bohlius","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.clnesp.2023.02.020_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1213\/00000539-197903000-00004","article-title":"Serum cholinesterase levels in patients with cancer","volume":"58","author":"Kaniaris","year":"1979","journal-title":"Anesth Analg"},{"key":"10.1016\/j.clnesp.2023.02.020_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tips.2012.05.003","article-title":"NSAIDs: endocannabinoid stimulating anti-inflammatory drugs?","volume":"33","author":"Fowler","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.clnesp.2023.02.020_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.18632\/oncoscience.289","article-title":"The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma","volume":"30","author":"Zhang","year":"2016","journal-title":"Oncoscience"},{"key":"10.1016\/j.clnesp.2023.02.020_bib34","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41598-019-38865-4","article-title":"Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer","volume":"9","author":"Grill","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2023.02.020_bib35","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jcsm.12855","article-title":"Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats","volume":"13","author":"Le Bacquer","year":"2022","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2023.02.020_bib36","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1210\/js.2019-00242","article-title":"Serum endocannabinoid levels in patients with end-stage renal disease","volume":"3","author":"Moradi","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.clnesp.2023.02.020_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpba.2015.03.017","article-title":"Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS\/MS: application in tumor-bearing mice","volume":"111","author":"Gong","year":"2015","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.clnesp.2023.02.020_bib38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0016-5085(03)00881-3","article-title":"Possible endocannabinoid control of colorectal cancer growth","volume":"125","author":"Ligresti","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2023.02.020_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012275","article-title":"Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4","volume":"5","author":"Thors","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2023.02.020_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11739-017-1610-3","article-title":"Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT","volume":"12","author":"Zaccaro","year":"2017","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.clnesp.2023.02.020_bib41","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.clnesp.2023.02.020_bib42","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201847258","article-title":"Energy metabolism in cachexia","volume":"20","author":"Rohm","year":"2019","journal-title":"EMBO Rep"},{"key":"10.1016\/j.clnesp.2023.02.020_bib43","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1016\/j.clnu.2021.02.016","article-title":"Cancer-associated anorexia: validity and performance overtime of different appetite tools among patients at their first cancer diagnosis","volume":"40","author":"Molfino","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2023.02.020_bib44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0115426505020004369","article-title":"The cancer cachexia syndrome: a review of metabolic and clinical manifestations","volume":"20","author":"Esper","year":"2005","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnesp.2023.02.020_bib45","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.npp.1300695","article-title":"Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa","volume":"30","author":"Monteleone","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clnesp.2023.02.020_bib46","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","article-title":"Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men","volume":"31","author":"C\u00f4t\u00e9","year":"2007","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnesp.2023.02.020_bib47","doi-asserted-by":"crossref","first-page":"E917","DOI":"10.1210\/jc.2011-3018","article-title":"Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study","volume":"97","author":"Monteleone","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2023.02.020_bib48","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ijo.2011.165","article-title":"Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity","volume":"36","author":"Gatta-Cherifi","year":"2012","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnesp.2023.02.020_bib49","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00394-016-1153-9","article-title":"Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity","volume":"55","author":"Monteleone","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnesp.2023.02.020_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/erv.2709","article-title":"Altered circulating endocannabinoids in anorexia nervosa during acute and weight-restored phases: a pilot study","volume":"28","author":"Piccolo","year":"2020","journal-title":"Eur Eat Disord Rev"},{"key":"10.1016\/j.clnesp.2023.02.020_bib51","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1210\/jc.2004-1145","article-title":"Increased melanin concentrating hormone receptor type I in the human hypothalamic infundibular nucleus in cachexia","volume":"90","author":"Unmehopa","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2023.02.020_bib52","doi-asserted-by":"crossref","first-page":"E1000","DOI":"10.1152\/ajpendo.90252.2008","article-title":"Neural control of the anorexia-cachexia syndrome","volume":"295","author":"Laviano","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2023.02.020_bib53","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/ijo.2009.67","article-title":"The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation","volume":"33","author":"Di Marzo","year":"2009","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnesp.2023.02.020_bib54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-3565(24)36812-0","article-title":"The biodisposition and metabolism of anandamide in mice","volume":"282","author":"Willoughby","year":"1997","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.clnesp.2023.02.020_bib55","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1124\/jpet.105.094748","article-title":"Ex\u00a0vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain","volume":"316","author":"Glaser","year":"2006","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.clnesp.2023.02.020_bib56","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.amjmed.2007.06.007","article-title":"Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?","volume":"120","author":"Kunos","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.clnesp.2023.02.020_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109800","article-title":"Functional heterogeneity of POMC neurons relies on mTORC1 signaling","volume":"37","author":"Saucisse","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.clnesp.2023.02.020_bib58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/oby.21687","article-title":"Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease","volume":"25","author":"Zelber-Sagi","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.clnesp.2023.02.020_bib59","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clnesp.2023.02.020_bib60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clnesp.2023.02.020_bib61","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/oby.22245","article-title":"Gene expression of endocannabinoid system components in skeletal muscle and adipose tissue of south asians and white caucasians with overweight","author":"Nahon","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.clnesp.2023.02.020_bib62","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41374-019-0327-5","article-title":"Cannabinoid receptor 1 knockout alleviates hepatic steatosis by downregulating perilipin 2","volume":"100","author":"Irungbam","year":"2020","journal-title":"Lab Invest"},{"key":"10.1016\/j.clnesp.2023.02.020_bib63","doi-asserted-by":"crossref","first-page":"25196","DOI":"10.1074\/jbc.C500175200","article-title":"Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase","volume":"280","author":"Kola","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clnesp.2023.02.020_bib64","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1038\/s41598-017-07980-5","article-title":"Endocannabinoid tone is higher in healthy lean South Asian than white Caucasian men","volume":"7","author":"Kantae","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2023.02.020_bib65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metabol"},{"key":"10.1016\/j.clnesp.2023.02.020_bib66","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clnesp.2023.02.020_bib67","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/ejn.12467","article-title":"Anandamide in primary sensory neurons: too much of a good thing?","volume":"39","author":"Sousa-Valente","year":"2014","journal-title":"Eur J Neurosci"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772300058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772300058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:10:51Z","timestamp":1762499451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240545772300058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":67,"alternative-id":["S240545772300058X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.02.020","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of circulating endocannabinoids with cancer cachexia: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}